Researchers use improved imaging technique and discover a better approach to diagnosing epilepsy

ScienceDaily (Aug. 2, 2011) — Using state-of-the-art, 7 Tesla magnetic resonance imaging (MRI) technology, University of Minnesota Medical School researchers may have uncovered a better approach to diagnosing epilepsy.

In the process, the team was able to cure eight patients of all epileptic symptoms.

Epilepsy, a neurological disorder causing repeated seizures or convulsions, impacts about one percent of the population, according to the National Institutes of Health (NIH). The most common type of epilepsy is temporal lobe epilepsy, caused by scarring inside the hippocampus, a major memory center of the brain. Many of these patients have severe memory problems, even in between seizures.

Using 7 Tesla MRI technology, a U of M research team led by University of Minnesota Physician neurologist Dr. Thomas Henry, scanned epileptic patients to capture extremely detailed images of their brain. (The strength of a magnetic field is measured in Tesla units. The higher the field strength, the more detailed the image acquired by MRI machines.)

While most standard clinical MRI machines have strength of 1.5 or 3 Tesla, the improved 7 Tesla technology allowed researchers to make highly-improved, detailed images of patients' brain tissue, especially the portion responsible for causing epilepsy.

The clearer MRI images allowed Henry and his colleagues to more accurately find scar tissue associated with temporal lobe epilepsy. Accurately locating this scarring is critical because if medications fail to control epileptic seizures, it's often possible for highly-trained neurosurgeons to remove scars from the brain in order to stop the seizures. The healthy parts of the brain left untouched, and actually begin to function better after seizures stop.

"There is huge potential here to improve patient care through improved approaches to magnetic resonance imaging," Henry said. "When you see how much clearer these 7 Tesla images are, compared with standard MRI, it's sort of like reading fine print with a magnifying glass versus the naked eye. The possibility of using 7 Tesla MRI to find brain lesions that were missed on current brain scans is likely to be very helpful in epilepsy and many other conditions."

Dr. Henry and his team conducted their research in the University of Minnesota's Center for Magnetic Resonance Research (CMRR), an interdisciplinary research laboratory that is home to the world's strongest imaging magnets and most sensitive scanners.

"Standard MRI technology is an effective way to diagnose epilepsy when it is caused by large lesions," said Henry. "We believe that by using 7 Tesla machines, which we have right at our fingertips on the University of Minnesota campus, we'll be able to treat a greater population of epileptic patients more effectively," said Henry.

The study was funded by the National Institutes of Health and the Keck Foundation. It appears in the online edition of the journal Radiology.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by University of Minnesota.

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

View the original article here sciencedaily.com

Researchers target, switch off serotonin-producing neurons in mice; New insights may be relevant to sudden infant death syndrome

ScienceDaily (July 28, 2011) — Researchers have developed a toolkit that enables them to turn off targeted cell populations while leaving others unaffected.

Led by Susan Dymecki, a professor of genetics at Harvard Medical School, the group focused on serotonin-producing neurons, observing how mice behave in a normal environment when suddenly their serotonin neurons are turned down. While their findings affirm earlier studies, the researchers used a technique that is non-invasive and does not require anesthesia, surgeries, or knocking out a gene -- each of which can cause problems when interpreting results.

"By selectively and abruptly switching off the serotonin-producing cells, we can get a definite idea of what bodily functions the serotonin cells specifically control," said Dymecki. "These findings and the new tools in neuroscience that it brings to the table will help us understand the role of serotonergic neurons in many human disorders."

One such disorder particularly relevant to these findings is Sudden Infant Death Syndrome, or SIDS.

These findings will appear in the July 29 edition of the journal Science.

The mammalian brain contains multiple chemical messengers, called neurotransmitters, which transfer information between nerve cells in order to regulate basic behaviors and functions like walking, eating, and sleeping. Serotonin is a major brain neurotransmitter produced solely by cells in the lower brain, or brainstem. Cells that make serotonin can convey information to large numbers of neurons distributed throughout the brain and can affect behavior as complex as mood.

In order to better understand how these serotonin-producing cells in the brain relate to basic physiology, Russell Ray and Rachael Brust, a postdoctoral researcher and a graduate student in Dymecki's lab, along with Jun Chul Kim, a prior postdoctoral fellow in Dymecki's lab who is now at the University of Toronto, and Andrea Corcoran, a postdoctoral researcher in the lab of Eugene Nattie at Dartmouth Medical School along with George Richerson, a professor of neurology at the University of Iowa, developed and characterized a method for selectively silencing neurons that produce serotonin.

The group began with a molecule genetically engineered by Bryan Roth and his colleagues at the University of North Carolina School of Medicine. Using a method that Dymecki's group had developed and optimized over the years called "intersectional genetics," they incorporated this molecule, a receptor, into the serotonin-producing brain cells in mice. As a result, the mice naturally generated this "unnatural" receptor on the surface of their serotoninergic neurons.

Receptors are key players in cellular communications, the initial recipients of chemical signals sent by other cells. Here, the researchers injected the mice with clozapine-N-oxide, a chemical compound designed to bind to and trigger the engineered receptor. Within minutes, the chemical and the foreign receptor acted together as a kind of dimmer switch, dampening the action of serotonin networks in the brains of these mice.

"This gave us the ability to selectively shut down serotonergic neuron function in the mouse brain," said Ray. "The mice remained awake, thus we could study their behavior in a normal environment."

When serotonergic neuron activity was diminished, the mice lost their capacity to maintain body temperature, and their temperatures plummeted to that of their surrounding environment.

Also, the ability of the mice to physiologically respond to elevations in carbon dioxide levels -- typically in the form of heavy, rapid breathing to rid the body of excessive carbon dioxide buildup before it might reach dangerous levels -- was roughly half that of normal mice when serotonergic neuron activity was low.

"What is particularly powerful to note is that we were able to study the mice both before and after we switched off the serotonergic neurons," said Ray. "We were able to demonstrate that prior to activating this foreign receptor switch -- that is prior to silencing the serotonin neurons -- the mice responded normally to temperature and carbon dioxide challenges."

The researchers believe this work may help us better understand the mechanisms underlying SIDS in humans.

Recent findings from the lab of Hannah Kinney at Children's Hospital Boston suggest that SIDS babies may have a deficiency of serotonin in circuits in the brainstem. Such deficiencies may lead directly to abnormal responses to elevated levels of carbon dioxide, such as when a baby rebreathes exhaled stale gases with high carbon dioxide levels while lying facedown.

"These infants may be vulnerable to sudden death due to impaired serotonin function in brainstem circuits important for protective responses to life threatening challenges, such as increased levels of carbon dioxide," said Dymecki. "What's more, a SIDS-vulnerable infant may be less equipped to maintain a normal body temperature."

Dymecki, along with her lab members and her colleagues at Dartmouth and University of Iowa, are now investigating how serotonergic neurons influence vital functions in young mice that are in the comparable age range to human infants at peak risk for SIDS. They also plan to use this genetic platform to selectively turn off subsets of serotonergic neurons, to better understand their specific functioning in health, and in other serotonin-linked disorders.

This research was funded by the National Institutes of Health.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Harvard Medical School. The original article was written by David Cameron.

Journal Reference:

R. S. Ray, A. E. Corcoran, R. D. Brust, J. C. Kim, G. B. Richerson, E. Nattie, S. M. Dymecki. Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition. Science, 2011; 333 (6042): 637 DOI: 10.1126/science.1205295

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

View the original article here